Intervenções de enfermagem à pessoa com risco de tromboembolismo venoso associado à quimioterapia: Scoping Review
português
DOI:
https://doi.org/10.31877/on.2024.50.04%20Palavras-chave:
Cancro, Cuidados de enfermagem, Prevenção primária e secundária, Quimioterapia, Tromboembolismo venosoResumo
Introdução: O tromboembolismo venoso é a segunda causa de morte na pessoa com cancro. Este risco aumenta em pessoas sob quimioterapia. Esta complicação provoca sofrimento físico e emocional, sendo fundamental intervenções de enfermagem dirigidas. Objetivo: Mapear a evidência científica sobre intervenções de enfermagem que permitem prevenir e gerir o tromboembolismo venoso na pessoa com doença oncológica sob quimioterapia. Métodos: Scoping Review segundo metodologia do Instituto Joanna Briggs. Pesquisa realizada nas bases de dados MEDLINE® e CINAHL® em abril de 2023. A revisão seguiu a checklist PRISMA-ScR EQUATOR.
Resultados: Incluídos 26 artigos, publicados entre 2004 e 2023. Após análise, emergiram três grandes dimensões: avaliação do risco de tromboembolismo venoso, intervenções autónomas e intervenções interdependentes. Conclusão: O enfermeiro é preponderante na prevenção e gestão do tromboembolismo venoso, recorrendo a uma abordagem sistematizada de avaliação do risco, educação e vigilância de sinais e/ou sintomas destas complicações e implementação de intervenções dirigidas.
Downloads
Referências
Direção-Geral da Saúde. Programa nacional para as doenças oncológicas 2017 [Internet]. 2017 [citado 25 de Abril de 2023]. Available at: https://comum.rcaap.pt/bitstream/10400.26/22531/1/Programa%20Nacional%20para%20as%20Doen%C3%A7as%20Oncol%C3%B3gicas%202017.pdf
Khorana A. Cancer and thrombosis: implications of published guidelines for clinical practice. Annals of Oncology. 2009;20(10):1619–30. https://doi.org/10.1093/annonc/mdp068
Mulder F, Horváth-Puhó E, Es N, Laarhoven H, Pedersen L, Moik F, et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood.2021;137(14):1959–69. https://doi.org/10.1182/blood.2020007338
Navi B, Reiner A, Kamel H, Iadecola C, Okin P, Elkind M, et al. Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol. 2017;70(8):926–38. https://doi.org/10.1016/j.jacc.2017.06.047
Mahajan A, Brunson A, Adesina O, Keegan T, Wun T. The incidence of cancer-associated thrombosis is increasing over time. Blood Adv. 2022;6(1):307–20. https://doi.org/10.1182/bloodadvances.2021005590
Donnellan E, Khorana A. Cancer and venous thromboembolic disease: A review. Oncologist. 2017;22(2):199–207. https://doi.org/10.1634/theoncologist.2016-0214
Falanga A, Ay C, Di Nisio M, Gerotziafas G, Jara-Palomares L, Langer F, et al. Venous thromboembolism in cancer patients: ESMO clinical practice guideline. Annals of Oncology.2023;34(5):452–67. https://doi.org/10.1016/j.annonc.2022.12.014
Renni M, Cerqueira M, Trugilho I, Junior M, Marques M, Koch H. Mecanismos do tromboembolismo venoso no câncer: uma revisão da literatura. J Vasc Bras. 2017;16(4):308–13. https://doi.org/10.1590/1677-5449.007817
Khorana A, Francis C, Culakova E, Kuderer N, Lyman G. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer.2007;110(10):2339–46. https://doi.org/10.1002/cncr.23062
Grover S, Hisada Y, Kasthuri R, Reeves B, Mackman N. Cancer therapy-associated thrombosis. Arterioscler Thromb Vasc Biol. 2021;41(4):1291–305. https://doi.org/10.1161/atvbaha.120.314378
Baddeley E, Torrens‐Burton A, Newman A, Nelson A, Pease N, Nelson R, et al. A mixed‐methods study to evaluate a patient‐designed tool to reduce harm from cancer‐associated thrombosis: The EMPOWER study. Res Pract Thromb Haemost. 2021;5(5):1–12. https://doi.org/10.1002/rth2.12545
Rossel A, Robert-Ebadi H, Marti C. Preventing venous thromboembolism in ambulatory patients with cancer: A Narrative Review. Cancers (Basel). 2020;12(3):1–14. https://doi.org/10.3390/cancers12030612
Streiff M, Holmstrom B, Angelini D, Ashrani A, Elshoury A, Fanikos J, et al. Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(10):1181–201. http://www.ncbi.nlm.nih.gov/pubmed/34666313
Bayadinova J, Sardo L, Higgins-Nogareda V, Scott J, MacKinnon B. «Spot the CLOT»: What cancer patients want to know. Canadian Oncology Nursing Journal. 2022;32(1):145–50. http://www.ncbi.nlm.nih.gov/pubmed/35280058
Noble S, Prout H, Nelson A. Patients’ experiences of living with cancer-associated thrombosis: the PELICAN study. Patient Prefer Adherence. 2015; 9:337–45. https://doi.org/10.2147/PPA.S79373
Ordem dos Enfermeiros. Regulamento no613/2022 que define o ato do enfermeiro. Diário da República, 2nd serie [internet]. 2022 [cited 25th April, 2023]; Part E (131): 179-82. Available at: https://www.ordemenfermeiros.pt/media/26674/regulamento-ato-do-enfermeiro.pdf
Morrison R. Venous thromboembolism: Scope of the problem and the nurse’s role in risk assessment and prevention. Journal of Vascular Nursing. 2006;24(3):82–90. https://doi.org/10.1016/j.jvn.2006.05.002
Holmes C, Ades S, Gilchrist S, Douce D, Libby K, Rogala B, et al. Successful model for guideline implementation to prevent cancer-associated thrombosis: venous thromboembolism prevention in the ambulatory cancer clinic. JCO Oncol Pract. 2020;16(9):e868–74. https://doi.org/10.1200/JOP.19.00697
Peters M, Godfrey C, McInerney P, Munn Z, Tricco A, Khalil H. Chapter 11: Scoping reviews. Em: Aromataris E, Munn Z, editores. JBI Manual for Evidence Synthesis. The Joanna Briggs Institute; 2020. https://doi.org/10.46658/JBIRM-19-01
Tricco A, Lillie E, Zarin W, O’Brien K, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018;169(7):467–73. https://doi.org/10.7326/M18-0850
World Health Organization. Older adolescent (15 to 19 years) and young adult (20 to 24 years) mortality [Internet]. World Health Organization;2022 [citado 4 de Março de 2024]. Disponível em: https://www.who.int/news-room/fact-sheets/detail/levels-and-trends-in-older-adolescent-%2815-to-19-years%29-and-young-adult-%2820-to-24-years%29-mortality
Bulechek G, Butcher H, Dochterman J. Classificação das intervenções de enfermagem (NIC). 5a. Guedes R, editor. Rio de Janeiro: Elsevier Editora Ltda.; 2010. 1–1037 p.
American Society of Clinical Oncology (ASCO). How Chemotherapy Drugs Work [Internet]. American Cancer Society, Inc. 2019 [Cited 2nd April, 2023]. Available at: https://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy/how-chemotherapy-drugs-work.html
Page M, Moher D, Bossuyt P, Boutron I, Hoffmann T, Mulrow C, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;373(160). https://doi.org/10.1136/bmj.n160
Spyropoulos A, Eldredge J, Anand L, Zhang M, Qiu M, Nourabadi S, et al. External validation of a venous thromboembolic risk score for cancer outpatients with solid tumors: The COMPASS-CAT venous thromboembolism risk assessment model. Oncologist. 2020;25(7): e1083–90. https://doi.org/10.1634/theoncologist.2019-0482
Viale PH. Abnormal clotting in cancer: An overview of pathophysiology and etiology. Semin Oncol Nurs. 2005;21(4):12–20. https://doi.org/10.1016/j.soncn.2005.10.013
Viale P, Schwartz R. Venous thromboembolism in patients with cancer part I: Survey of oncology nurses’ attitudes and treatment practices for ambulatory settings. Clin J Oncol Nurs. 2004;8(5):455–61. DOI:10.1188/04.CJON.455-461
Khorana A, Rao M. Approaches to risk-stratifying cancer patients for venous thromboembolism. Thromb Res. 2007;120(2):S41–50. https://doi.org/10.1016/S0049-3848(07)70129-9
Kuderer N, Lyman G. Guidelines for treatment and prevention of venous thromboembolism among patients with cancer. Thromb Res. 2014;133: S122–7. https://doi.org/10.1016/S0049-3848(14)50021-7
Dutia M, White RH, Wun T. Risk assessment models for cancer‐associated venous thromboembolism. Cancer. 2012;118(14):3468–76. https://doi.org/10.1002/cncr.26597
Angelini D, Khorana A. Risk assessment scores for cancer-associated venous thromboembolic disease. Semin Thromb Hemost. 2017;43(05):469–78. https://doi.org/10.1055/s-0036-1597281
Ashrani A, Gullerud R, Petterson T, Marks R, Bailey K, Heit J. Risk factors for incident venous thromboembolism in active cancer patients: A population based case–control study. Thromb Res. 2016; 139:29–37. https://doi.org/10.1016/j.thromres.2016.01.002
Cunningham R. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis. Semin Oncol. 2006;33(4):17–25. https://doi.org/10.1053/j.seminoncol.2006.01.022
Lyman G, Bohlke K, Khorana A, Kuderer N, Lee A, Arcelus J, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. Journal of Clinical Oncology. 2015;33(6):654–6. https://doi.org/10.1200/JCO.2014.59.7351
Key N, Khorana A, Kuderer N, Bohlke K, Lee A, Arcelus J, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update. Journal of Clinical Oncology. 2023;41(16):3063–71. https://doi.org/10.1200/JCO.23.00294
Sardo L, Bayadinova J, Jenkins S, Penton L. The significance of VTE in cancer: Introduction of the «Spot the Clot» series. Canadian oncology nursing journal. 2021;31(4):500–3. Disponível em: http://www.ncbi.nlm.nih.gov/pubmed/34786471
Bayadinova J, Sardo L, Penton L, Jenkins S. «Spot the CLOT»: Awareness of cancer-associated thrombosis in healthcare providers. Canadian Oncology Nursing Journal. 2022; 32(2):325–30. Disponível em: https://europepmc.org/article/MED/35582246
Nisio M, van Es, Rotunno L, Anzoletti N, Falcone L, Tursi M, et al. Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients. J Thromb Thrombolysis. 2019;48(1):125–33. https://doi.org/10.1007/s11239-019-01845-6
Fu J, Cai W, Zeng B, He L, Bao L, Lin Z, et al. Development and validation of a predictive model for peripherally inserted central catheter-related thrombosis in breast cancer patients based on artificial neural network: A prospective cohort study. Int J Nurs Stud. 2022; 135:1–8. https://doi.org/10.1016/j.ijnurstu.2022.104341
Kirschner M, Hartmann N, Parmentier S, Hart C, Henze L, Bisping G, et al. Primary thromboprophylaxis in patients with malignancies: Daily practice recommendations by the hemostasis working party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO). Cancers (Basel). 2021;13(12):1–27. https://doi.org/10.3390/cancers13122905
Syrigos K, Grapsa D, Sangare R, Evmorfiadis I, Larsen A, Van Dreden P, et al. Prospective assessment of clinical risk factors and biomarkers of hypercoagulability for the identification of patients with lung adenocarcinoma at risk for cancer-associated thrombosis: The observational ROADMAP-CAT Study. Oncologist. 2018;23(11):1372–81. https://doi.org/10.1634/theoncologist.2017-0530
Farge D, Bosquet L, Kassab-Chahmi D, Mismetti P, Elalamy I, Meyer G, et al. 2008 french national guidelines for the treatment of venous thromboembolism in patients with cancer: Report from the working group. Crit Rev Oncol Hematol. Janeiro de 2010;73(1):31–46. https://doi.org/10.3390/cancers12030618
Hilário T, Mantovani V, Aliti G, Lucena A, Rabelo-Silva E. Trombose: análise de conceito como subsídio teórico para qualificar a prática clínica de enfermeiros. Online Brazilian Journal of Nursing. 2022; 21:1–11. https://doi.org/10.17665/1676-4285.20226580
Lyman G, Carrier M, Ay C, Nisio M, Hicks L, Khorana A, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021;5(4):927–74. https://doi.org/10.1182/bloodadvances.2020003442
Dias I, Marins A, Franco A, Carvalho E, Souza N, Andrade K. Avaliação de risco para tromboembolismo venoso: estudo bibliométrico para a prática clínica de cardioncologia. Revista Enfermagem Atual In Derme. 2022;96(39):1–16. https://doi.org/10.31011/reaid-2022-v.96-n.39-art.1438
Overvad T, Ording A, Nielsen P, Skjøth F, Albertsen I, Noble S, et al. Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy. Blood Adv. 2022;6(10):2967–76. https://doi.org/10.1182/bloodadvances.2021006484
Haggstrom L, Parmar G, Brungs D. Central venous catheter thrombosis in cancer: A Multi-centre retrospective study investigating risk factors and contemporary trends in management. Clin Med Insights Oncol. 2020;14:1–6. https://doi.org/10.1177/1179554920953097
Falanga A, Russo L, Milesi V, Vignoli A. Mechanisms and risk factors of thrombosis in cancer. Crit Rev Oncol Hematol. 2017; 118:79–83. https://doi.org/10.1016/j.critrevonc.2017.08.003
Riegel B, Jaarsma T, Strömberg A. A Middle-Range Theory of Self-Care of Chronic Illness. Advances in Nursing Science. 2012;35(3):194–204. DOI: 10.1097/ANS.0b013e318261b1ba
Liz-Pimenta J, Tavares V, Neto B, Santos J, Guedes C, Araújo A, et al. Thrombosis and cachexia in cancer: Two partners in crime? Crit Rev Oncol Hematol. 2023; 186:1–15. https://doi.org/10.1016/j.critrevonc.2023.103989
Silva S, Santos J, Silva M, Costa R, Medeiros R. Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle. 2020;11(3):619–35. https://doi.org/10.1002/jcsm.12528
Potere N, Barco S, Mahé I, Cesarman-Maus G, Angchaisuksiri P, Leader A, et al. Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day. J Thromb Haemost. 2022;20(12):2964–71. https://doi.org/10.1111/jth.15902
Vidigal P, Garcia T, Santos M, Camacho A, Souto M, Borges G, et al. Subconjunto terminológico CIPE® para pacientes com tromboembolismo venoso associado a câncer. Acta Paulista de Enfermagem. 2018;31(4):382–90. https://doi.org/10.1590/1982-0194201800054
Xu L, Fu C, Zhang Q, He C, Wei Q. The effectiveness of exercise training in treating venous thromboembolism: a systematic review. Vol. 49, Physician and Sportsmedicine. Taylor and Francis Ltd.; 2020. p. 1–11. https://doi.org/10.1080/00913847.2020.1786746
Downloads
Publicado
Como Citar
Edição
Secção
Licença
Direitos de Autor (c) 2025 Ana Isabel Marcelino, Patrícia Matos Martins, Ana Inês Frade, Susana Sofia Abreu Miguel, Maria Alexandra Santos da Costa
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição-NãoComercial-CompartilhaIgual 4.0.
